Spoiler alert: Yes.
Even if this is entirely about equity, it’s a strange call. Monoclonal antibody treatment saves lives, and should be distributed based on need. Most medicines and treatments don’t have to get distributed by the federal government, but for those that do because of shortage conditions, are any distributed on the basis of prioritizing equity over demand?
This smells a bit like retribution for red-state governors not playing along with Biden’s demands for mandates and masks. That aroma arises from Biden himself, who vowed last week to get even with such governors to “get them out of the way.” The timing is suspicious in more ways than one, too: